JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB120289

TMCB, Selective CK2 inhibitor

Be the first to review this product! Submit a review

|

(2 Publications)

MW 534.82 Da, Purity >98%. CK2 inhibitor (Ki = 0.25 μM), more selective than DMAT. Unlike DMAT, TMCB displays selectivity over PIM1, HIPK2 and DYRK1a (Ki values are 8.65, 15.25 and 11.90 μM, respectively) and a more favourable selectivity profile over a range of other kinases.
3 Images
Immunocytochemistry/ Immunofluorescence - TMCB, Selective CK2 inhibitor (AB120289)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - TMCB, Selective CK2 inhibitor (AB120289)

ab23423 staining cIAP2 in HeLa cells treated with TMCB (ab120289), by ICC/IF. Decrease in cIAP2 expression correlates with increased concentration of TMCB, as described in literature.
The cells were incubated at 37°C for 10 minutes in media containing different concentrations of ab120289 (TMCB) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab23423 (5 µg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 goat anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.

Functional Studies - TMCB, Selective CK2 inhibitor (AB120289)
  • FuncS

Unknown

Functional Studies - TMCB, Selective CK2 inhibitor (AB120289)

HeLa cells were incubated at 37°C for 24h with vehicle control (0 μM) and different concentrations of TMCB (ab120289). Decreased expression of cIAP2 in HeLa cells correlates with an increase TMCB concentration as described in literature.

Whole cell lysates were prepared with RIPA buffer (containing protease inhibitors and sodium orthovanadate) 40 μg of each were loaded on the gel and the WB was run under reducing conditions. After transfer the membrane was blocked for an hour using 5% BSA before being incubated with ab23423 at 2 μg/ml and ab1801 at 2 μg/ml overnight at 4°C. Antibody binding was detected using an anti-rabbit antibody conjugated to HRP (ab97051) at 1/10000 dilution and visualised using ECL development solution.

Chemical Structure - TMCB, Selective CK2 inhibitor (AB120289)
  • Chemical Structure

Lab

Chemical Structure - TMCB, Selective CK2 inhibitor (AB120289)

2D chemical structure image of ab120289, TMCB, Selective CK2 inhibitor

Key facts

CAS number

905105-89-7

Purity

>98%

Form

Solid

form

Molecular weight

534.82 Da

Molecular formula

C<sub>1</sub><sub>1</sub>H<sub>9</sub>Br<sub>4</sub>N<sub>3</sub>O<sub>2</sub>

PubChem

46943415

Nature

Synthetic

Solubility

Soluble in DMSO to 25 mM (with heating)

Biochemical name

[4,5,6,7-Tetrabromo-2-(Dimethylamino)-1h-Benzimidazol-1-Yl]acetic Acid

Biological description

CK2 inhibitor (Ki = 0.25 μM), more selective than DMAT. Unlike DMAT, TMCB displays selectivity over PIM1, HIPK2 and DYRK1a (Ki values are 8.65, 15.25 and 11.90 μM, respectively) and a more favourable selectivity profile over a range of other kinases.

Canonical smiles

CN(C)C1=NC2=C(N1CC(=O)O)C(=C(C(=C2Br)Br)Br)Br

InChi

InChI=1S/C11H9Br4N3O2/c1-17(2)11-16-9-7(14)5(12)6(13)8(15)10(9)18(11)3-4(19)20/h3H2,1-2H3,(H,19,20)

InChiKey

PHAOTASRLQMKBE-UHFFFAOYSA-N

IUPAC Name

2-[4,5,6,7-tetrabromo-2-(dimethylamino)benzimidazol-1-yl]acetic acid

Properties and storage information

Shipped at conditions
Ambient - Can Ship with Ice
Appropriate short-term storage conditions
Ambient
Appropriate long-term storage conditions
Ambient
Storage information
The product can be stored for up to 12 months

Product protocols

Publications (2)

Recent publications for all applications. Explore the full list and refine your search

Journal of virology 93: PubMed31511391

2019

Serine 229 Balances the Hepatitis C Virus Nonstructural Protein NS5A between Hypo- and Hyperphosphorylated States.

Applications

Unspecified application

Species

Unspecified reactive species

Chia-Ni Tsai,Ting-Chun Pan,Cho-Han Chiang,Chun-Chiao Yu,Shih-Han Su,Ming-Jiun Yu

Antiviral research 91:259-66 PubMed21722672

2011

CK2 inhibitors increase the sensitivity of HSV-1 to interferon-β.

Applications

Unspecified application

Species

Unspecified reactive species

Miles C Smith,Adam M Bayless,Erica T Goddard,David J Davido
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com